INTRODUCTION
Controlled drug delivery systems offer numerous advantages over conventional dosages forms, including improved efficacy, reduce toxicity, and improved patient compliance, and can be utilized in the form of nanocarriers in drug delivery [1] . Nanoparticles are solid colloidal particles with diameters ranging from 1 -1000 nm [2] . They consist of macromolecular materials in which the active ingredient is dissolved, entrapped, encapsulated, adsorbed or chemically attached [3] . They may be prepared from a variety of materials such as proteins, polysaccharides and synthetic polymers. The selection of materials is dependent on many factors including: (a) size of nanoparticles required; (b) inherent properties of the drug, e.g., solubility and stability; (c) surface characteristics such as charge and permeability; (d) degree of biodegradability, biocompatibility and toxicity; and (e) drug release profile desired [4] . Nanotechnologies are attractive candidates for the delivery of, amongst others, antibiotics in infections caused by bacteria.
Generally, encapsulation of antibiotics in nanoparticles increases the maximal tolerated dose and therapeutic index of antibiotics when compared with the free drug [5] [6] [7] . The entrapment of ampicillin in poly(isobutylcyanoacrylate) nanoparticles increased 120-fold the efficacy of the antibiotic in an experimental acute infection of mice by Salmonella typhimurium.
Most nanoparticles prepared from waterinsoluble polymers are subjected to heat, organic solvent or high shear force during production and this may be harmful to drug stability.
Moreover, some preparation methods such as emulsion polymerization and solvent evaporation are complex, and require a number of preparation steps that are time and energy consuming. In contrast, water-soluble polymers offer mild and simple preparation methods without the use of organic solvent and high shear force. Among water-soluble polymers available, chitosan is one of the most extensively studied. This is because chitosan possesses some ideal properties of a polymeric carrier for nanoparticles such as biocompatibility, biodegradability, non-toxicity, and low cost. It possesses a positive charge and exhibits an absorption enhancing effect. This characteristic can be employed to prepare cross-linked chitosan nanoparticles. The mechanism of chitosan Chitosan nanoparticle formation is usually based on electrostatic interaction between the amine group of chitosan and a negatively charged group or polyanion such as tripolyphosphate [8] . Furthermore, it possesses antimicrobial property and adsorbs toxic metals such as mercury, cadmium, lead, etc [9] ..
In the present study, chitosan nanoparticles containing ampicillin trihydrate were prepared using ionic gelation method assisted by sonication. The developed systems were characterized for size, shape, zeta-potential, entrapment efficiency and in-vitro release. They were also assessed for anti-microbial activity against Staphylococcus aureus.
EXPERIMENTAL Materials
Ampicillin trihydrate IP was purchased from Aurobindo Pharma Ltd, Hyderabad and chitosan from Central Institute of Fisheries Technology, Cochin, India. Glacial acetic acid, beef extract powder, sodium tripolyphosphate and yeast extract powder were obtained from Merck Specialties Private Limited, Mumbai, India. All other chemicals used were of analytical grade.
Preparation of nanoparticles
Blank chitosan nanoparticles were prepared by ionic gelation method. Different concentrations of polymer, ranging from 0.10 to 0.75 %w/v, were dissolved in 1.5 %v/v acetic acid solution. Sodium tripolyphosphate solution was also prepared in distilled water in concentrations ranging from 0.10 to 0.75 %w/v. Sodium tripolyphosphate solution was added dropwise with a syringe to chitosan solution while stirring, followed by sonication for 20 min. The resulting suspension was subsequently centrifuged at 15000 rpm for 10 min. The pellets obtained were re-suspended in deionised water by sonication, centrifuged and dried at room temperature (about 25 0 C.
Drug-loaded chitosan nanoparticles were formed spontaneously upon dropwise addition of 12 ml of 0.4 % aqueous sodium tripolyphosphate solution to 20 ml of 0.35 %w/v chitosan solution containing 2 -5 mg/ml of the drug under magnetic stirring, followed by sonication. The resulting nanoparticle suspensions were centrifuged 4 times (15 min each) at 15000 rpm, washed with distilled water and dried.
Determination of zeta potential
The zeta potential of the drug-loaded chitosan nanoparticles was measured on a zetasizer (Malvern Instruments) by determining the electrophoretic mobility in a microelectrophoresis flow cell [10-11]. All the samples were measured in water at 25 °C in triplicate..
Measurement of mean particle size
The mean size of the nanoparticles was determined by photocorrelation spectroscopy (PCS) on a submicron particle size analyzer (Malvern Instruments) at a scattering angle of 90° [12] . A sample (0.5mg) of the nanoparticles suspended in 5 ml of distilled water was used for the measurement.
Determination of particle morphology
Particle morphology was determined by scanning electron microscopy (Jeol JSM-6480LV, NIT, Rourkela, India). Dried particles were taken in a piece of black tape and attached to the sample holder. Particle morphology was determined under low vacuum.
Determination of entrapment efficiency
The
Entrapment efficiency (%) = (Tp -Tf)100/Tp … (1) where Tp is the total ampicillin trihydrate used to prepare the nanoparticles and Tf is the free ampicillin trihydrate in the supernatant
Evaluation of in vitro drug release
The ampicillin trihydrate loaded chitosan nanoparticles, after separation by ultracentrifugation, were re-dispersed in 5mL 0.2 mol/L phosphate buffer solution PBS solution (pH 7.4), placed in a dialysis membrane bag, tied and immersed in 150mL of PBS in a 250ml beaker. The entire system was stirred continuously at 37 °C with a magnetic stirrer. At pre-determined time intervals, 5mL of the release medium was removed and replaced with 5mL of fresh PBS solution. The amount of ampicillin trihydrate in the release medium was evaluated by UV spectrophotometry at 257nm.
Assessment of antimicrobial activity
Nutrient agar media (pH 6.5-6.6), composed of the following ingredients, was prepared: peptone (1.2 g), pancreatic digest of casein (0.8 g), yeast extracts (0.6 g), beef extract (0.3 g), dextrose (0.2 g) and agar (3 g).
The strain selected for the study, Staphylococcus aureus, was cultured on the nutrient agar medium. The cup plate technique was used. Nutrient agar plates were prepared by pouring 20 ml autoclaved nutrient agar into a sterile Petri dish. Four cups each of 8mm diameter were prepared by scooping out medium with a sterilized cork borer. Prior to this, the agar was streaked with the organism. The solution of each formulation -0.2 ml of ampicillin trihydrate (5 µg/ml), 0.06 ml of blank nanoparticles (without drug), 0.06ml of drug-loaded nanoparticles (0.015 mg/ml) and 0.025 ml of a commercial formulation of ampicillin trihydrate (0.04mg/ml)) -were added separately to the cups and the Petri dishes incubated for 48 h at 37 ± 2 °C. Zone of inhibition was determined after 12, 24 and 48 h to evaluate the extent of bacterial inhibition by the preparations. All the experiments were performed in triplicate.
Statistical analysis
In vitro results of different formulations were compared statistically to understand the level of significance using PAST statistical software. The results are presented as mean ± standard deviation (S.D.). Student's t-test was used to compare mean values of different groups for the determination of antimicrobial activity. Statistical significance was set at p < 0.05.
RESULTS
The most satisfactory nanoparticles were obtained at a chitosan concentration of 0.35 %w/v and sodium tripolyphosphate concentration of 0.40 %w/v.
Entrapment efficiency
The concentration of drug for optimal entrapment of drug in the nanoparticles was 4 mg/ml. The data (see Table 1 ) revealed that drug entrapment efficiency was dependent on polymer concentration.
Zeta potential, particle size, morphology and polydispersity
As Table 1 shows, the size of the nanoparticles decreased after sonication while zeta potential was unchanged. Zeta potential was over +20 mV for all formulations while polydispersity index was less than 0.3, which indicates homogeneous nature of the formulation. Sonication for 20 min reduced particle size to nano level; thereafter, there was no further change in particle size. Although the particles fell within nanosize range (200 -500 nm) [13] , they were, however, irregular in shape (see Fig. 1 ). 
In vitro drug release
The in vitro release data in Fig 2 indicate that the drug-loaded formulation obtained after sonication exhibited sustained release behavior with a steady rise in cumulative drug release (> 70 %) up to the 15 th hour. Thereafter, there was no further significant release of the drug. Table 2 indicates that all the test preparations containing the drug, including the drugloaded chitosan nanoparticles, demonstrated significantly greater zone of inhibition (p < 0.05) than the blank nanoparticles (i.e., without drug). Chitosan is a biocompatible, biodegradable and natural polymer. It appeared to have good compatibility with the entrapped ampicillin trihydrate as there was no clear evidence of interaction between the two compounds. Thus, nanoparticles prepared by ionic gelation method using chitosan as polymer and sodium tripolyphosphate as crosslinking agent produced particles of good stability. Entrapment of the drug within the gel network of the chitosan matrix may have made the formulation more stable. It seems that the relatively lower viscosity of chitosan with a concentration as low as 0.35 %) and an appropriate concentration of TPP (0.4 %w/v) promoted the formation of nanoparticles. A fixed sonication time of 20 min yielded smaller and more uniform nanoparticles. This may be attributed to the fact that at this concentration, optimum viscosity was attained by chitosan solution for nanoparticle formation. Sonication time was also an important parameter for nanoparticle formation probably because sonication helped to reduce particle size.
Antimicrobial activity
Zeta potential of the developed formulation was in the range of 34 -37 mV, which suggests that the formulation was fairly stable. The higher zeta potential indicate that chitosan nanoparticles were stable. It seems likely that the long amino groups hinder anion adsorption and keep high the value of the electrical double layer thickness, and thus preventing aggregation. The polydispersity data reinforce this assertion. Furthermore, the SEM image showed that each particle unit exhibited a nanostructure. The nanoparticles also exhibited sustained drug release behavior. While chitosan has its own antibacterial activity, it is clear that incorporation of ampicillin trihydrate in the chitosan nanoparticles produced synergism. Compared with the commercial preparation of ampicillin trihydrate (reference), the drugloaded nanoparticles exhibited similar antibacterial activity within the first 12 h but thereafter, showed higher activity.
CONCLUSION
This work confirms that modified ionic gelation method is useful for the development of chitosan nanoparticles. The concentration of polymer and crosslinking agent as well as sonication time are important factors in the development of ampicillin trihydrate nanoparticles. The inherent antimicrobial properties of chitosan can be exploited for the formulation of nanoparticle formulations of antimicrobial agents.
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